GSK Investigational Site
Bellaire, Texas 77401
We've found
2 trials
at this facility
Infection, Human Immunodeficiency Virus Clinical Trial
Updated: 3/5/2018
GSK1265744 (Cabotegravir, CAB) for Named Patient/Compassionate Use in HIV
Status: Enrolling,
Phase
Updated: 3/5/2018
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials